BMI View: The mid-term outlook for Kazakhstan's pharmaceutical and healthcare markets is mixed. The
healthcare system is set to improve, with the introduction of a public health insurance system and e-health
technology; however, the formation of the Eurasian Economic ..."
BMI View: The establishment of a national health insurance fund will markedly boost sales of
pharmaceuticals in Kazakhstan. A reliance on foreign pharmaceutical imports, the population's increasing
access to healthcare and the government's long-term vision to become a ..."
BMI View: Kazakhstan's pharmaceutical market will continue to grow at a rapid pace over our forecast
period. Its accession into the Eurasian Economic Union (EAEU) will lead to access to better quality drugs
at lower prices, increasing consumption as the country forms ..."
BMI View: Although pharmaceutical sales grew at a slower pace than we previously forecast in 2014,
Kazakhstan's pharmaceutical market will maintain its rapid local currency growth rate over the long term.
The government will continue to support increased healthcare ex ..."
BMI View: Declining real incomes will moderate the demand for pharmaceuticals in Kazakhstan in the
short-term. However, continued expansion in government procurement will offset this and contribute to top
line growth. With the government increasingly tying market acce ..."
BMI View: Within the pharmaceutical sector, the Kazakh government is looking to reduce its import
reliance and also to serve its growing healthcare needs. In light of the Kazakh government's commitment to
ramping up healthcare expenditure and incentivising foreign inv ..."
BMI View: Plans to boost government spending on healthcare will be positive for the pharmaceutical
industry as well as other participants in the healthcare sector. Over the longer term, the introduction of
compulsory health insurance will create a large pool of fundin ..."
BMI View: Kazakhstan's healthcare sector suffers from a lack of trained medical professionals and the
inherent difficulties of providing infrastructure and access to healthcare in such a large country. However,
the government continues to show its commitment to improv ..."
BMI View: Kazakhstan's expanding pharmaceutical industry will continue to be primarily driven by the
demand for generic drugs, which currently make up over a third of total sales of the market, as the
government makes more progress in its efforts to widen the country' ..."
BMI View: As a new member of the Customs Union, Kazakhstan will impose a tariff on imported
pharmaceuticals. This will moderately impact medium term growth in the pharmaceutical market as
demand for medicines is driven by private consumption. Nevertheless, we expect p ..."